Last updated: July 27, 2025
Introduction
South Korea’s patent KR20190004843 pertains to a pharmaceutical innovation filed under the Korean Intellectual Property Office (KIPO). This patent's scope, claims, and landscape are critical for understanding its strength, exclusivity, and potential impact on the pharmaceutical market. This detailed analysis dissects the patent’s technical scope, claims structure, and position within the evolving Korean patent environment relevant to medicinal compounds and formulations.
Patent Overview and Technical Background
KR20190004843 was published on January 10, 2019, indicating a priority date possibly in 2018. The patent relates primarily to a novel pharmaceutical composition, often targeting a specific active agent or therapeutic method.
The patent’s technical background revolves around the development of a specific drug formulation or method—likely focusing on enhanced stability, bioavailability, or reduced side effects. It may also involve a novel compound, salt forms, or delivery mechanism designed to improve treatment efficacy.
Claims Analysis
Claims are the legal backbone of the patent, defining the scope and territorial rights. A typical patent such as KR20190004843 will include:
- Independent Claims: Define the broadest scope, covering the core invention.
- Dependent Claims: Add specific features or embodiments, narrowing scope but reinforcing patent strength.
Key issues in claims structure for KR20190004843:
- Whether claims encompass the active compound only, formulation, methods of preparation, or therapeutic use.
- The degree of breadth: Do claims cover only a specific compound or a broader class of related compounds?
- Inclusion of method claims: Indicating if it's a composition patent or method patent.
Sample hypothetical claim breakdown:
- An isolated compound of formula X, wherein the compound exhibits activity Y.
- A pharmaceutical composition comprising the compound of claim 1 and excipients.
- A method for treating disease Z by administering the composition of claim 2.
Assessment:
- The scope’s strength depends on claim specificity. Broader claims covering a class of compounds or formulations provide wider protection but are more susceptible to invalidation via prior art.
- Claims involving methods or use provide separate layers of protection, crucial for commercial applications.
Patent Scope
The scope of KR20190004843 appears to focus on:
- Chemical structure and salts of a specific compound or class.
- Pharmaceutical formulations optimized for particular delivery or stability.
- Therapeutic applications targeting a specific disease or condition.
- Potential inclusion of methodology clauses for preparation or administration.
This scope is typical for early-stage patenting in pharmaceuticals, emphasizing the novelty and inventive step of a drug molecule or formulation.
Patent Landscape and Landscape Analysis in South Korea
South Korea is renowned for a robust pharmaceutical IP regime, with a focus on:
- Strong patent protection for chemical compounds, formulations, and indications.
- Rapid innovation cycles driven by domestic firms like Samsung BioLogics, Celltrion, and LG Chem.
- A patent landscape characterized by a high density of filings in biologics, generics, and drug delivery systems.
In the context of KR20190004843:
- The patent exists within a competitive environment of chemical and therapeutic patents, with numerous filings targeting similar indications or compound classes.
- South Korea’s patent system favors early and broad patent filings to establish sector-specific dominance.
Precedent and prior art:
Standard practice involves searching for prior art involving similar chemical structures, formulations, or methods. The patent appears to navigate around prior art by claiming specific structural features, unique salts, or formulations not previously disclosed.
Patentability of KR20190004843 is reinforced by:
- Demonstrated inventive step over prior art focusing on similar compounds or formulations.
- The specificity of claims, potentially covering proprietary salts or delivery methods.
Legal and Commercial Implications
For patent holders:
- Successfully enforcing the patent grants exclusive rights in South Korea for up to 20 years from filing, instrumental in recouping R&D investments.
- The scope influences potential licensing, collaborations, or defensive patenting strategies.
For competitors:
- The claims’ breadth determines ease of designing around.
- The advanced patent landscape in South Korea necessitates careful position assessment to avoid infringement or to challenge weak patents.
Conclusion
KR20190004843 exemplifies a carefully constructed pharmaceutical patent, focusing on a specific compound or formulation with therapeutic relevance. Its scope, centered on structural and formulation claims, aligns with South Korea’s proactive patenting approach, securing early-stage market exclusivity in a competitive landscape.
The patent landscape in South Korea emphasizes strategic patenting in biologics and chemical compounds, aligning with global trends toward biologics and innovative small molecules. Companies must continually monitor such patents to carve out clear freedom-to-operate, validate patent strength, or challenge weak claims.
Key Takeaways
-
Scope and Claims:
KR20190004843’s claims likely focus on specific chemical structures, salts, formulations, and methods of preparation, with scope tailored to withstand prior art challenges while maintaining market exclusivity.
-
Patent Strength:
Broad claims encompassing a class of compounds or formulations enhance protection, but narrow claims limit vulnerability to invalidation.
-
Landscape Context:
South Korea’s dynamic pharmaceutical patent environment favors early innovation protection, especially for biologics, chemical entities, and delivery methods.
-
Strategic Implication:
Patent holders may leverage this patent to establish market dominance, while competitors should consider licensing or design-around strategies.
-
Legal Consideration:
Enforcement and potential challenges depend heavily on claim clarity, prior art, and patent prosecution quality.
FAQs
1. What is the primary focus of KR20190004843?
It pertains to a specific pharmaceutical composition, likely involving a novel compound, salt form, or formulation designed to improve therapeutic efficacy or stability.
2. How broad are the claims in KR20190004843?
While specific details depend on the patent’s exact wording, the claims probably range from specific compounds to broader formulations or therapeutic methods, balancing protection and construct validity.
3. How does this patent compare to global pharma patenting trends?
It aligns with Korea’s emphasis on early, strategic patent filings covering chemical structures, formulations, and methods, similar to trends in the US and Europe.
4. Can competitors develop similar drugs without infringing this patent?
Yes, if they design around the specific claims, such as creating structurally different compounds or alternative formulations outside the patent’s scope.
5. What is the significance of this patent for the Korean pharmaceutical market?
It may provide a competitive edge in developing proprietary drugs, enabling exclusive marketing rights and fostering further R&D investment.
References
- Korean Intellectual Property Office. Patent Publication KR20190004843.
- WIPO. Patent Landscape Reports.
- South Korea Intellectual Property Office (KIPO). Patent Examination Guidelines.
